Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial

Daniel K. Burns, Robert Alexander, Kathleen A. Welsh‐Bohmer, Meredith Culp, Carl Chiang, Janet O’Neil, Rebecca M. Evans, Patrick J. Harrigan, Brenda L. Plassman, James R. Burke,

The Lancet Neurology · 2021 · 117 citations · 23 references

Concepts

References

23